6

6 Cited Publications

CAS No.: 1198398-71-8

Category:

Alkaloids Chelidonium majus Metabolic Disease Quinoline Alkaloids Plants Disease Research Fields Papaveraceae Extract

Target:

Indoleamine 2,3-Dioxygenase (IDO) NF-κB p38 MAPK PI3K Akt Apoptosis Reactive Oxygen Species (ROS) Mitochondrial Metabolism DNA/RNA Synthesis ROCK LDLR

Coptisine Sulfate is an orally active and brain-penetrant alkaloid found in Coptis chinensis. Coptisine Sulfate is a reversible, uncompetitive IDO inhibitor with a K_i of 5.8 μM and an IC₅₀ of 6.3 μM. Coptisine Sulfate suppresses neuroinflammation, reduces Aβ plaque burden and shows neuroprotective activity. Coptisine Sulfate shows anti-inflammation activity by blocking NF-κB, MAPK, and PI3K/Akt activation. Coptisine Sulfate inhibits cancer cells proliferation, induces DNA damage, G2/M phase cell cycle arrest, apoptosis, ROS production and mitochondrial dysfunction. Coptisine Sulfate inhibits Rho/ROCK pathway activation, reduces arrhythmia, limits cardiac injury marker release, reduces infarct size, and preserves cardiac function in rat myocardial ischemia/reperfusion models. Coptisine Sulfate downregulates HMGCR and upregulates LDLR and CYP7A1 to modulate cholesterol metabolism, reduces abnormal serum lipid levels, and promotes fecal bile acid excretion. Coptisine Sulfate be used for the research of cancer, hypercholesterolemia, Alzheimer’s disease, inflammatory disorders and cardiovascular disease .

Compare

loading...

Please select quantity

August 31

Obtenir un devis

View All Sizes

5

Acetoacetic acid sodium

5 Cited Publications

Cat. No.: HY-112540B

CAS No.: 623-58-5

Pureté: ≥98.0%

Category:

Human Gut Microbiota Metabolites Ketones, Aldehydes, Acids Metabolic Disease Endogenous metabolite Disease Research Fields

Target:

Endogenous Metabolite

Acetoacetic acid sodium is an oxidative stress inducer that affects the antioxidant enzyme system and lipoprotein metabolism. Acetoacetic acid sodium induces oxidative stress by decreasing the mRNA expression and activity of superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GSH-Px), increasing MDA content, and inhibiting very low density lipoprotein (VLDL) assembly by downregulating apolipoprotein ApoB100, ApoE, and low density lipoprotein receptor (LDLR), leading to triglyceride (TG) accumulation in hepatocytes. Acetoacetic acid sodium can be used to study metabolic diseases .

Compare

loading...

Please select quantity

August 31

Obtenir un devis

View All Sizes

5

Acetoacetic acid

5 Cited Publications

Cat. No.: HY-112540

CAS No.: 541-50-4

Category:

Human Gut Microbiota Metabolites Microorganisms Endogenous metabolite

Target:

Endogenous Metabolite

Acetoacetic acid is an oxidative stress inducer that affects the antioxidant enzyme system and lipoprotein metabolism. Acetoacetic acid induces oxidative stress by decreasing the mRNA expression and activity of superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GSH-Px), increasing MDA content, and inhibiting very low density lipoprotein (VLDL) assembly by downregulating apolipoprotein ApoB100, ApoE, and low density lipoprotein receptor (LDLR), leading to triglyceride (TG) accumulation in hepatocytes. Acetoacetic acid can be used to study metabolic diseases .

Compare

loading...

Please select quantity

August 31

Obtenir un devis

View All Sizes

5

Acetoacetic acid lithium

5 Cited Publications

Cat. No.: HY-112540A

CAS No.: 3483-11-2

Pureté: ≥98.0%

Category:

Ketones, Aldehydes, Acids Metabolic Disease Endogenous metabolite Disease Research Fields

Target:

Endogenous Metabolite

Acetoacetic acid lithium is an oxidative stress inducer that affects the antioxidant enzyme system and lipoprotein metabolism. Acetoacetic acid lithium induces oxidative stress by decreasing the mRNA expression and activity of superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GSH-Px), increasing MDA content, and inhibiting very low density lipoprotein (VLDL) assembly by downregulating apolipoprotein ApoB100, ApoE, and low density lipoprotein receptor (LDLR), leading to triglyceride (TG) accumulation in hepatocytes. Acetoacetic acid lithium can be used to study metabolic diseases .

Compare

loading...

Please select quantity

August 31

Obtenir un devis

View All Sizes

3

Evolocumab

3 Cited Publications

Cat. No.: HY-P9930

CAS No.: 1256937-27-5

Synonyms: AMG 145

Target:

NF-κB Ser/Thr Protease Toll-like Receptor (TLR)

Domaines de recherche:

Cardiovascular Disease Metabolic Disease Inflammation/Immunology Cancer

Evolocumab (AMG 145) is a human monoclonal antibody that inhibits PCSK9. Evolocumab is used in the study of hypercholesterolemia and atherosclerotic cardiovascular disease. Evolocumab binds to circulating PCSK9 protein and inhibits its binding to LDLR. Evolocumab has antioxidant and cytoprotective activities against H₂O₂-induced oxidative damage to endothelial cells. Evolocumab may also negatively regulate activation of the TLR-4/NF-κB signaling pathway to prevent inflammation .

Compare

loading...

Please select quantity

August 31

Obtenir un devis

View All Sizes

2

LDLR Protein, Human (HEK293, His)

2 Cited Publications

Cat. No.: HY-P70235

Pureté: ≥ 95%, as determined by reducing SDS-PAGE.

Synonyms: LDLR; LDL Receptor; Low Density Lipoprotein Receptor; Low-Density Lipoprotein Receptor Class A Domain-Containing Protein 3; Low-Density Lipoprotein Receptor; Familial Hypercholesterolemia; LDLCQ2; Low Density Lipoprotein

Species:

Human

Source:

HEK293

Compare

loading...

Please select quantity

August 31

Obtenir un devis

View All Sizes

1

Laroprovstat

1 Cited Publications

Cat. No.: HY-148673

CAS No.: 2455427-91-3

Pureté: 99.97%

Synonyms: AZD0780; PCSK9-IN-12

Target:

PCSK9

Domaines de recherche:

Cardiovascular Disease Metabolic Disease

Laroprovstat (AZD0780) is an orall active PCSK9 inhibitor. PCSK9-IN-12 has bind affinity for PCSK9 with a K_d value of <200 nM. Laroprovstat binds to a pocket in the PCSK9 C-terminal domain and does not affect the PCSK9-LDL receptor (LDLR) interaction. Laroprovstat inhibits lysosomal trafficking of PSCK9-LDLR complexes and prevents PCSK9-induced LDLR degradation. Laroprovstat can be used for the research of hypercholesterolemia .

Compare

loading...

Please select quantity

August 31

Obtenir un devis

View All Sizes

1

PCSK9-IN-11

1 Cited Publications

Cat. No.: HY-152223

CAS No.: 2882035-56-3

Pureté: 99.66%

Target:

PCSK9

Domaines de recherche:

Cardiovascular Disease

PCSK9-IN-11 (compound 5r) is a potent and orally active PCSK9 inhibitor. PCSK9-IN-11 exhibits PCSK9 transcriptional inhibitory activity in HepG2 cells, with an IC₅₀ of 5.7 μM. PCSK9-IN-11 increases LDL receptor (LDLR) protein level. PCSK9-IN-11 can be used for atherosclerosis research .

Compare

loading...

Please select quantity

August 31

Obtenir un devis

View All Sizes

Rebaudioside A

Cat. No.: HY-N0466

CAS No.: 58543-16-1

Category:

Plants Endogenous metabolite Sweeteners Food Research 500 - Internal Server Error | MedChemExpress

country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Country or Region:

United States

Cart

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

Oops!

Sorry, Something went wrong on our server.
Our team has been notified and is working to fix the issue.

LDL-R

Oops!